Lv11
30 积分 2022-01-04 加入
Dyslipidemia progression and increased lung cancer risk: a prospective cohort study
3小时前
待确认
[Chinese expert consensus on lipid management in patients with malignancy]
3小时前
已完结
Development and validation of an interpretable risk prediction model for the early classification of thalassemia
9天前
已完结
Role for Artificial Intelligence in the Detection of Immune-Related Adverse Events
22天前
已完结
Harnessing big data to characterize immune-related adverse events
22天前
已完结
Immune checkpoint therapy—current perspectives and future directions
22天前
已完结
Peak Corticosteroid Dose for Immune-Related Adverse Events and Survival: Not the Whole Story
22天前
已完结
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
1个月前
已完结
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
1个月前
已完结
Second cancer incidence in CLL patients receiving BTK inhibitors
2个月前
已完结
皖公网安备34019202002308
